 RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--TransEnterix, Inc. NYSE American: TRXC TransEnterix or the Company, a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into an underwriting agreement with H.C. Wainwright Co. under which the underwriter has agreed to purchase on a firm commitment basis 8,333,334 shares of common stock of the Company at a public offerin 